|
CZ295502B6
(cs)
*
|
1997-03-26 |
2005-08-17 |
Janssen Pharmaceutica N. V. |
Antifungální peleta, způsob její přípravy a farmaceutická dávková forma s obsahem těchto pelet
|
|
AU4679999A
(en)
*
|
1998-06-11 |
1999-12-30 |
Em Industries, Inc. |
Micro-osmotic controlled drug delivery systems
|
|
DK1104291T3
(da)
|
1998-07-17 |
2006-01-16 |
Janssen Pharmaceutica Nv |
Pelleter med en kerne, som er coatet med et antisvampemiddel og en polymer
|
|
ES2157731B1
(es)
*
|
1998-07-21 |
2002-05-01 |
Liconsa Liberacion Controlada |
Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
|
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
FR2795961B1
(fr)
*
|
1999-07-09 |
2004-05-28 |
Ethypharm Lab Prod Ethiques |
Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
|
|
US7863331B2
(en)
|
1999-07-09 |
2011-01-04 |
Ethypharm |
Pharmaceutical composition containing fenofibrate and method for the preparation thereof
|
|
KR100694667B1
(ko)
*
|
1999-12-08 |
2007-03-14 |
동아제약주식회사 |
생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
|
|
US6663897B2
(en)
*
|
2001-02-06 |
2003-12-16 |
Dsm Ip Assets B.V. |
Oral itraconazole formulations and methods of making the same
|
|
EP1842532A3
(en)
*
|
2001-02-06 |
2009-04-22 |
Stiefel Laboratories, Inc. |
Oral sparingly water-soluble antifungal formulations and methods of making the same
|
|
FR2842736B1
(fr)
|
2002-07-26 |
2005-07-22 |
Flamel Tech Sa |
Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
|
|
ITMI20031096A1
(it)
*
|
2003-05-30 |
2004-11-30 |
Eurand Spa |
Microcapsule per coacervazione contenenti farmaco incorporato nel polimero di rivestimento
|
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
|
WO2016033549A2
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
|
WO2016205423A2
(en)
|
2015-06-15 |
2016-12-22 |
Lipocine Inc. |
Composition and method for oral delivery of androgen prodrugs
|
|
CN105949278B
(zh)
*
|
2016-03-30 |
2019-12-06 |
南京曼杰生物科技有限公司 |
一种取代的四氢呋喃水溶性衍生物及其应用
|
|
CA3078723A1
(en)
|
2016-11-28 |
2018-05-31 |
Nachiappan Chidambaram |
Oral testosterone undecanoate therapy
|
|
EP3824296B1
(en)
|
2018-07-20 |
2026-04-01 |
Lipocine Inc. |
Oral pharmaceutical composition comprising testosterone tridecanoate and/or testosterone dodecanoate for treating liver diseases
|